Zepp Health (NYSE:ZEPP) Earns "Sell (D-)" Rating from Weiss Ratings

Key Points

• Zepp Health (NYSE:ZEPP) received a "sell (D-)" rating from Weiss Ratings, indicating analysts' concerns about the stock's performance.
• The stock price of Zepp Health fell 3.4% to $43.01, with a current market capitalization of approximately $623.57 million.
• Despite its low rating, about 52.61% of Zepp Health's stock is owned by hedge funds and institutional investors, indicating some level of institutional confidence.

Zepp Health (NYSE:ZEPP - Get Free Report)'s stock had its "sell (d-)" rating reiterated by stock analysts at Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

Other equities analysts have also issued research reports about the stock. Wall Street Zen raised shares of Zepp Health to a "hold" rating in a research report on Saturday, August 16th. Fundamental Research set a $60.23 price objective on shares of Zepp Health and gave the company a "buy" rating in a research report on Tuesday, August 26th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $60.23.

Zepp Health Stock Down 3.4%

ZEPP traded down $1.52 during midday trading on Friday, hitting $43.01. 451,376 shares of the company's stock traded hands, compared to its average volume of 287,012. The company has a market cap of $623.57 million, a PE ratio of -8.89 and a beta of 1.32. The stock's fifty day simple moving average is $47.60 and its 200-day simple moving average is $20.81. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.10 and a quick ratio of 0.78. Zepp Health has a one year low of $2.13 and a one year high of $61.85.

Hedge Funds Weigh In On Zepp Health

An institutional investor recently bought a new position in Zepp Health stock. Ariose Capital Management Ltd bought a new position in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 27,717 shares of the company's stock, valued at approximately $1,269,000. Zepp Health accounts for about 0.4% of Ariose Capital Management Ltd's portfolio, making the stock its 27th biggest holding. Ariose Capital Management Ltd owned about 0.19% of Zepp Health at the end of the most recent reporting period. 52.61% of the stock is owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.